Management Review Under ISO 13485
Management review is a critical quality management system element that demonstrates top management’s engagement with and oversight of the quality system. Under ISO 13485:2016 Clause 5.6, organizations must conduct management reviews at planned intervals to ensure the continuing suitability, adequacy, and effectiveness of the quality management system. With the adoption of the QMSR by the FDA, management review records are now subject to regulatory inspection, elevating the importance of conducting thorough, well-documented reviews.
The management review serves multiple purposes: it provides top management with a comprehensive view of quality system performance, it enables informed decision-making about resource allocation and improvement priorities, it satisfies regulatory requirements for management oversight, and it creates a documented record of management engagement with quality.
For medical device companies, management review is not just a compliance exercise — it is a strategic management tool that connects quality system performance with business outcomes. Organizations that leverage management review effectively use it to align quality objectives with business strategy, allocate resources to the highest-priority quality needs, and drive continuous improvement across the organization.
Required Inputs for Medical Device Management Review
ISO 13485:2016 specifies a comprehensive list of inputs that must be considered during management review. These inputs ensure that the review addresses all aspects of quality system performance. Required inputs include feedback including complaints, reporting to regulatory authorities such as adverse event reports and advisory notices, audit results from both internal and external audits, monitoring and measurement of processes and product, corrective and preventive action status, follow-up actions from previous management reviews, changes that could affect the quality management system including new or revised regulatory requirements, and recommendations for improvement.
In addition to these standard inputs, medical device companies should consider post-market surveillance data and trends, supplier quality performance, training and competence status, design and development project status, and regulatory intelligence about evolving requirements and enforcement trends. The more comprehensive the inputs, the more informed the management decisions.
Each input should be supported by data and analysis rather than general statements. For example, complaint trending should include quantitative data showing complaint rates by product and by type, with comparison to previous periods and identification of any notable trends or anomalies.
Generating Meaningful Outputs
Management review outputs must include decisions and actions related to improvement of the effectiveness of the quality management system and its processes, improvement of product related to customer requirements, and resource needs. These outputs must be documented and should be specific enough to enable implementation and accountability tracking.
Effective outputs include specific improvement initiatives with defined scope, objectives, and resources. Resource allocation decisions that address identified needs. Quality objective updates that reflect current priorities and performance. And action items with assigned owners, target dates, and defined deliverables.
The management review record should document not only what was decided but why — providing the rationale that connects inputs to outputs. This documentation demonstrates that management decisions are informed and deliberate, which is the standard that regulators assess during inspections.
Common Deficiencies in Medical Device Management Review
Auditors frequently identify several categories of management review deficiencies. Incomplete inputs — where some required inputs are addressed while others are omitted — result in management decisions based on an incomplete picture of quality system performance. Superficial analysis that presents data without interpretation or trend identification fails to provide the insights management needs for informed decision-making.
Weak outputs that lack specificity — such as continue monitoring or maintain current course — suggest that the review did not produce meaningful management engagement. Auditors look for evidence that the review resulted in specific decisions and actions, not just acknowledgment of the data presented.
Poor follow-up on previous action items indicates a management review process that lacks accountability. Each review should begin with a status report on actions from the previous review, and persistent open items should be escalated for management attention.
Strengthening Management Review Through Independent Assessment
An independent audit of the management review process can identify opportunities to strengthen this critical quality system element. Experienced auditors evaluate not only the documentation but the substance of management reviews — whether they represent genuine management engagement with quality system performance and produce meaningful decisions that drive improvement.
Regular independent assessment of management review helps medical device companies maintain the level of management engagement and oversight that both ISO 13485 and the FDA QMSR require.
Implementation Considerations and Best Practices
Successful implementation requires careful planning, adequate resources, and sustained management commitment. Organizations should begin by conducting a thorough assessment of their current practices against the requirements discussed in this article. This baseline assessment identifies specific gaps that need to be addressed and provides a foundation for prioritizing improvement activities based on risk and regulatory impact.
Resource allocation is a critical success factor. Organizations must ensure that sufficient personnel, training, equipment, and time are dedicated to implementation efforts. Under-resourced implementation attempts often result in superficial changes that do not achieve genuine compliance or process improvement. Management must recognize that quality system investments produce returns in the form of reduced regulatory risk, improved product quality, greater customer satisfaction, and enhanced operational efficiency.
Training is another essential element. Personnel at all levels must understand the requirements applicable to their roles and must be competent to perform their quality-related responsibilities. Training should cover both the regulatory basis for requirements and the practical procedures the organization has established to meet them. Effectiveness of training should be evaluated through testing, observation, or other appropriate methods to ensure that competence has been achieved.
Documentation must be complete, current, and accessible. Quality system documentation provides the framework within which personnel operate, and records provide evidence that activities have been performed as planned. Organizations should invest in documentation management systems that support version control, accessibility, and retention while preventing the use of obsolete documents.
Partner with Qualyx Group
At Qualyx Group, we specialize in independent, audit-only services for regulated industries. Our experienced auditors bring deep domain expertise, bilingual capabilities, and an unwavering commitment to objectivity. Whether you need a gap analysis, a supplier audit, or preparation for an upcoming regulatory inspection, we are here to help.
Contact Qualyx Group today to discuss how our independent audit services can strengthen your quality system and support your compliance goals.